Literature DB >> 9921608

Assessing treatment-time interaction in clinical trials with time to event data: a meta-analysis of hypertension trials.

F Boutitie1, F Gueyffier, S J Pocock, J P Boissel.   

Abstract

Exploration of the variation of treatment effect over time in randomized clinical trials with low event rates is limited by lack of power. A meta-analysis on individual patient data from such trials can partly solve the problem, but brings other computational difficulties. Using an example in hypertension, we describe appropriate methods for graphical description and statistical modelling of treatment-time interactions in large data sets. Also, a method is developed for determining the total number of events required to detect treatment-period interactions of plausible magnitude. We conclude that trialists tend to overinterpret the observed data when looking for potential treatment-time interactions by visual comparisons of survival curves, failing to realize the substantial amounts of data that are needed for their detection and estimation.

Entities:  

Mesh:

Year:  1998        PMID: 9921608     DOI: 10.1002/(sici)1097-0258(19981230)17:24<2883::aid-sim900>3.0.co;2-l

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

Review 1.  Is blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) and the Biomarker-Surrogacy (BioSurrogate) Evaluation Schema (BSES).

Authors:  Marissa N Lassere; Kent R Johnson; Michal Schiff; David Rees
Journal:  BMC Med Res Methodol       Date:  2012-03-12       Impact factor: 4.615

2.  Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials.

Authors:  Justin J O'Hagan; Miguel A Hernán; Rochelle P Walensky; Marc Lipsitch
Journal:  AIDS       Date:  2012-01-14       Impact factor: 4.177

3.  How much of the recent decline in the incidence of myocardial infarction in British men can be explained by changes in cardiovascular risk factors? Evidence from a prospective population-based study.

Authors:  Sarah L Hardoon; Peter H Whincup; Lucy T Lennon; S Goya Wannamethee; Simon Capewell; Richard W Morris
Journal:  Circulation       Date:  2008-01-22       Impact factor: 29.690

4.  One-stage parametric meta-analysis of time-to-event outcomes.

Authors:  F Siannis; J K Barrett; V T Farewell; J F Tierney
Journal:  Stat Med       Date:  2010-10-20       Impact factor: 2.373

5.  Rising adiposity curbing decline in the incidence of myocardial infarction: 20-year follow-up of British men and women in the Whitehall II cohort.

Authors:  Sarah L Hardoon; Richard W Morris; Peter H Whincup; Martin J Shipley; Annie R Britton; Gabriel Masset; Silvia Stringhini; Séverine Sabia; Mika Kivimaki; Archana Singh-Manoux; Eric J Brunner
Journal:  Eur Heart J       Date:  2011-06-08       Impact factor: 29.983

6.  Treatment of high blood pressure and gain in event-free life expectancy.

Authors:  Behrouz Kassaï; Jean-Pierre Boissel; Michel Cucherat; Florent Boutitie; François Gueyffier
Journal:  Vasc Health Risk Manag       Date:  2005

Review 7.  Effect model law: an approach for the implementation of personalized medicine.

Authors:  Jean-Pierre Boissel; Riad Kahoul; Draltan Marin; François-Henri Boissel
Journal:  J Pers Med       Date:  2013-08-15

Review 8.  Investigating clinical heterogeneity in systematic reviews: a methodologic review of guidance in the literature.

Authors:  Joel J Gagnier; David Moher; Heather Boon; Joseph Beyene; Claire Bombardier
Journal:  BMC Med Res Methodol       Date:  2012-07-30       Impact factor: 4.615

Review 9.  Individual participant data meta-analysis of intervention studies with time-to-event outcomes: A review of the methodology and an applied example.

Authors:  Valentijn M T de Jong; Karel G M Moons; Richard D Riley; Catrin Tudur Smith; Anthony G Marson; Marinus J C Eijkemans; Thomas P A Debray
Journal:  Res Synth Methods       Date:  2020-02-06       Impact factor: 5.273

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.